Clinical trial Recruiting at 1 site Interventional Ages 18 to 70

Milrinone vs Epinephrine on TAPSE after cardiopulmonary bypass

Official title: Milrinone Versus Epinephrine for Right Ventricular Dysfunction After Cardiac Surgery in Adults: A Randomized Double-Blinded Trial

Run by Mansoura University · NCT07144267 · Data updated 2026-11-12

This study tests whether milrinone or epinephrine better supports right ventricular function (TAPSE) after cardiac surgery with CPB in adults.

Quick facts

Study typeInterventional
Ages18 Years to 70 Years
SexAll
Enrollment102 (estimated)
SponsorMansoura University
Academic / other
Locations1 site (Al Mansurah)
StatusRecruiting
StartedMarch 1, 2026
Main results expectedDecember 30, 2028
Study endsMarch 30, 2029
Registry record updatedOctober 13, 2026
Trial IDNCT07144267 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18–70 undergoing CPB with TAPSE < 1.7 cm and preserved ejection fraction (>40%), ASA II–III, without major contraindications to TEE or significant renal/hepatic disease.

Probably not a fit

Patients with preoperative RV impairment, severe pulmonary hypertension, redo surgeries, or significant organ dysfunction may not benefit from this approach.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study compares two inotropes, milrinone and epinephrine, to see which more effectively supports right ventricular function after cardiopulmonary bypass. Eligible adults undergoing CPB with adequate ejection fraction and TAPSE below a threshold will be randomized to receive one of the two drugs. The trial evaluates changes in TAPSE and related hemodynamics to determine which agent better preserves right ventricular performance in the immediate postoperative period. Safety and tolerability of both agents will be monitored per standard perioperative care. The investigation is conducted at Mansoura University Hospitals with sponsor support from Mansoura University.

Why it matters

Potential benefit: If successful, the findings could help tailor inotrope choice to protect right heart function after CPB, potentially reducing complications and improving recovery.

How similar studies have gone: Prior research supports distinct hemodynamic effects of milrinone and epinephrine in cardiac surgery, but direct head-to-head data on TAPSE after CPB are limited, making this approach relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* American Society of Anesthesiologists (ASA) physical status II \& III
* Age between 18 and 70 years
* Both Gender
* Body mass index less than 40 kg/m2
* Ejection fraction of \>40%
* Tricuspid annular plane systolic excursion (TAPSE) \< 1.7cm

Exclusion Criteria:

* Patient refusal.
* Preoperative RV impairment
* Pulmonary hypertension (estimated pulmonary artery systolic pressure \> 50 mmHg)
* Patients with any contraindications to Transesophageal echocardiography (TEE)
* Redo or Re-exploration surgery
* Patients with chronic kidney disease (serum creatinine \> 1.5 mg/ dl)
* Patients with chronic liver disease (child pugh B and C)

Where it's running

  • Mansoura University Hospitals
    Al Mansurah, Egypt
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.